Biogen to Present Plegridy Data from Phase 3 Study at AAN Annual Meeting

By: via Benzinga
– Two-Year Data Consistent with Positive Efficacy and Safety Observed in Year One – – Additional Analyses of Year-One ADVANCE ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.